Heart Failure and Therapeutic Education (NCT07006350) | Clinical Trial Compass
CompletedNot Applicable
Heart Failure and Therapeutic Education
France104 participantsStarted 2025-03-24
Plain-language summary
This study looks at whether a special program called the Heart Failure Therapeutic Education Unit (UTIC) helps reduce hospital stays for people with heart failure. It is a retrospective study, which means we are looking back at the records of patients who were followed at the UTIC in 2023 and 2024.
We want to find out two things:
If patients who followed the UTIC program were hospitalized less often.
If the advice they received-especially about diet-helped improve their condition.
Only adult patients who were treated at the UTIC are included in the study. We will not use data from patients who are under 18, were not treated in UTIC, or did not give permission to use their information.
The study takes place over two weeks, from March 24 to April 6, 2025.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Adults (age ≥ 18 years)
* Patients diagnosed with heart failure
* Patients followed in the Heart Failure Therapeutic Education Unit (UTIC) at the General Hospital (CHG)
* Follow-up occurred during the years 2023 or 2024
Exclusion Criteria:
* Patients who do not consent to the use of their medical data
* Minors (under 18 years old)
* Patients not followed in the UTIC program
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Number of hospitalizations among patients with heart failure who were followed at the Unité Thérapeutique de l'Insuffisance Cardiaque (UTIC).
Timeframe: Review of hospital records for patients seen in 2023-2024.